Safc

SAFC expands ADC and bulk drug manufacturing in CA, MO

13-May-2015 By Fiona BARRY

SAFC has announced investments in gene therapy manufacturing sites in Missouri and California.

SAFC launches new CHO lines for protein drug developers

01-Oct-2013

A new knock-out cell line developed by SAFC promises to make crystallography studies more effective and –potentially – safer therapeutic proteins.

SAFC to be renamed under Sigma-Aldrich business rejig

22-Nov-2012

Sigma-Aldrich has announced a plan to realign its business operations along regional and customer-focused lines.  

SAFC and Novozymes Biopharma extend partnership in exclusive growth hormone distribution

19-Aug-2010 By Alexandria Pesic

SAFC and Novozymes Biopharma have agreed to extend their partnership by ten years for the exclusive distribution of LONG R3 growth factor, used for industrial cell culture applications.

H1N1 adjuvants help SAFC in Q4; Sigma sales down in 2009

17-Feb-2010 By Gareth Macdonald

Revenues fell 3 per cent in 2009 at SAFC but pharmaceutical sector demand for vaccine manufacturing products helped firm finish year with six months of growth.

SAFC takes on transgenics and India

18-Oct-2006 By Kirsty Barnes

Sigma-Aldrich Group member SAFC made its presence felt at the
recent CPhI in Paris with announcements regarding its expansion
activities in transgenic manufacturing and India.